SHC-Transforming Protein 4 (SHC4) Antibody
312€ (60 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
SHC-Transforming Protein 4 (SHC4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx005792
tested applications
IF/ICC
Description
SHC4 Antibody is a Rabbit Polyclonal Antibody against SHC4.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | SHC-Transforming Protein 4 (SHC4) |
| Host | Rabbit |
| Reactivity | Human, Mouse |
| Recommended Dilution | IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 60 µl |
| Size 2 | 120 µl |
| Size 3 | 200 µl |
| Form | Liquid |
| Tested Applications | IF/ICC |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q6S5L8 |
| Gene ID | 399694 |
| NCBI Accession | NP_976224.3 |
| Alias | RaLP,SHCD,SHC-transforming protein D,SH2 domain protein C4,SHC-transforming protein 4 |
| Background | Antibody anti-SHC4 |
| Status | RUO |
| Note | Concentration: 1 mg/ml - |
Descripción
SHC4, also known as RaLP (SHC-related adaptor protein-like protein), is a member of the SHC family of adaptor proteins involved in receptor tyrosine kinase (RTK) signaling. It contains the PTB and SH2 domains that mediate interactions with phosphorylated receptors and downstream signaling intermediates, activating pathways such as Ras/MAPK and PI3K/Akt to regulate processes like cell proliferation, survival, and differentiation. SHC4 is primarily expressed in neural tissues and certain cancers, where it plays an important role in neuronal development, axon guidance, and survival signaling. Dysregulation or overexpression of SHC4 is associated with tumorigenesis, particularly in melanoma and glioblastoma, where it promotes cellular proliferation, migration, and resistance to apoptosis. Knockdown studies reveal impaired cell growth, disrupted signaling pathways, and reduced tumorigenic potential, highlighting its critical function in mediating oncogenic and neuronal signaling pathways.
Related Products
SHC4 antibody
Activates both Ras-dependent and Ras-independent migratory pathways in melanomas. Contributes to the early phases of agrin-induced tyrosine phosphorylation of CHRNB1.
Ver Producto
SHC-Transforming Protein 4 (SHC4) Antibody
SHC4 Antibody is a Rabbit Polyclonal Antibody against SHC4.
Ver Producto
Mouse Shc4 Antibody
Activates both Ras-dependent and Ras-independent migratory pathways in melanomas. Contributes to the early phases of agrin-induced tyrosine phosphorylation of CHRNB1.
Ver Producto